This Week: UK Regulator Denies Coverage of Spravato for Third Time Innerwell Launches At-Home Ketamine-Assisted Therapy Offering Canada Allows British Columbia to Trial 3-Year Decriminalisation Experiment and more… Third Time Unlucky: UK Regulator Again Denies Coverage of Spravato (esketamine) The UK’s National Institute for Health and Care Excellence (NICE), which decides which therapeutics the…


Previous articlePT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants
Next articleThe Intertwined Prohibitionist Histories of Psychedelics and Kratom